Goodpasture's disease: Molecular architecture of the autoantigen provides clues to etiology and pathogenesis

Current Opinion in Nephrology and Hypertension

Volumn 20, Issue 3, 2011, Pages 290-296

  Pedchenko, Vadim ^a   Vanacore, Roberto ^a   Hudson, Billy ^a,b,c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b Department of Pathology ^*  (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

autoantibodies; autoantigen; collagen type IV; epitopes; glomerular basement membrane; Goodpasture's disease

Indexed keywords

ALLOANTIBODY; AUTOANTIBODY; AUTOANTIGEN; COLLAGEN TYPE 4; EPITOPE;

BINDING AFFINITY; CHEMICAL STRUCTURE; CONFORMATIONAL TRANSITION; DISEASE COURSE; GENETIC HETEROGENEITY; GOODPASTURE SYNDROME; IMMUNOLOGICAL TOLERANCE; KIDNEY FUNCTION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; REVIEW; STRUCTURE ANALYSIS; TARGET ORGAN;

ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; AUTOANTIBODIES; AUTOANTIGENS; EPITOPES; HUMANS; PROTEIN CONFORMATION;

EID: 79954999141     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0b013e328344ff20     Document Type: Review

References (57)

1. Salama AD, Levy JB, Light stone L, Pusey CD. Goodpasture's disease. Lancet 2001; 358:917-920. (Pubitemid 32900581)
2. Wilson CB, Dixon FJ. Antiglomerular basement membrane antibody-induced glomerulonephritis. Kidney Int 1973; 3:74-89.
3. Lockwood CM, Rees AJ, Pearson TA, et al. Immunosuppression and plasmaexchange in the treatment of Goodpasture's syndrome. Lancet 1976; 1:711-715.
4. Lerner RA, Glassock RJ, Dixon FJ. The role of antiglomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med 1967; 126:989-1004.
5. Butkowski RJ, Langeveld JP, Wieslander J, et al. Localization of the Goodpasture epitope to a novel chain of basement membrane collagen. J Biol Chem 1987; 262:7874-7877.
6. Saus J, Wieslander J, Langeveld JP, et al. Identification of the Goodpasture antigen as the alpha 3(IV) chain of collagen IV. J Biol Chem 1988; 263:13374-13380.
7. Leinonen A, Netzer KO, Boutaud A, et al. Goodpasture antigen: expression of the full-length alpha3(IV) chain of collagen IV and localization of epitopes exclusively to the noncollagenous domain. Kidney Int 1999; 55:926-935. (Pubitemid 29100704)
8. Turner N, Mason PJ, Brown R, et al. Molecular cloning of the human Goodpasture antigen demonstrates it to be the alpha 3 chain of type IV collagen. J Clin Invest 1992; 89:592-601.
9. Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG. Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med 2003; 348:2543-2556. (Pubitemid 36706542)
10. Kalluri R, Gattone VH 2nd, Noelken ME, Hudson BG. The alpha 3 chain of type IV collagen induces autoimmune Goodpasture syndrome. Proc Natl Acad Sci USA 1994; 91:6201-6205.
11. Abbate M, Kalluri R, Corna D, et al. Experimental Goodpasture's syndrome in Wistar-Kyoto rats immunized with alpha3 chain of type IV collagen. Kidney Int 1998; 54:1550-1561. (Pubitemid 28502897)
12. Sado Y, Boutaud A, Kagawa M, et al. Induction of anti-GBMnephritis in rats by recombinant a3(IV)NC1 and a4(IV)NC1 of type IV collagen. Kidney Int 1998; 53:664-671. (Pubitemid 28124281)
13. Nishibayashi S, Hattori K, Hirano T, et al. Functional and structural changes in end-stage kidney disease due to glomerulonephritis induced by the recombinant alpha3(IV)NC1 domain. Exp Anim 2010; 59:157-170.
14. Abrahamson DR, Hudson BG, Stroganova L, et al. Cellular origins of type IV collagen networks in developing glomeruli. J Am Soc Nephrol 2009; 20:1471-1479.
15. Boutaud A, Borza DB, Bondar O, et al. Type IV collagen of the glomerular basement membrane: evidence that the chain specificity of network assembly is encoded by the noncollagenous NC1 domains. J Biol Chem 2000; 275:30716-30724.
16. Borza DB, Bondar O, Todd P, et al. Quaternary organization of the Goodpasture autoantigen, the alpha 3(IV) collagen chain. Sequestration of two cryptic autoepitopes by intrapromoter interactions with the alpha4 and alpha5 NC1 domains. J Biol Chem 2002; 277:40075-40083. (Pubitemid 35190997)
17. Sundaramoorthy M, Meiyappan M, Todd P, Hudson BG. Crystal structure of NC1 domains. Structural basis for type IV collagen assembly in basement membranes. J Biol Chem 2002; 277:31142-31153. (Pubitemid 34970820)
18. Ooi JD, Holdsworth SR, Kitching AR. Advances in the pathogenesis of Goodpasture's disease: from epitopes to autoantibodies to effector T cells. J Autoimmun 2008; 31:295-300.
19. Zhou XJ, Lv JC, Zhao MH, Zhang H. Advances in the genetics of antiglomerular basement membrane disease. Am J Nephrol 2010; 32:482-490. Critical review of genetic predisposition factors in anti-GBM disease, including single nucleotide polymorphism and copy number variation of FCgR family.
20. Peto P, Salama AD. Update on antiglomerular basement membrane disease. Curr Opin Rheumatol 2011; 23:32-37.
21. Segelmark M, Hellmark T, Wieslander J. The prognostic significance in Goodpasture's disease of specificity, titre and affinity of antiglomerular- basement- membrane antibodies. Nephron Clin Pract 2003; 94:c59-c68.
22. Yang R, Hellmark T, Zhao J, et al. Levels of epitope-specific autoantibodies correlate with renal damage in anti-GBM disease. Nephrol Dial Transplant 2009; 24:1838-1844.
23. Cui Z, Zhao MH. Avidity of antiglomerular basement membrane autoantibodies was associated with disease severity. Clin Immunol 2005; 116:77-82. (Pubitemid 40733585)
24. Pedchenko V, Bondar O, Fogo AB, et al. Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. N Engl J Med 2010; 363:343-354.
25. Hellmark T, Johansson C, Wieslander J. Characterization of anti-GBM antibodies involved in Goodpasture's syndrome. Kidney Int 1994; 46:823-829. (Pubitemid 24272041)
26. Kalluri R, Wilson CB, WeberM, et al. Identification of the alpha 3 chain of type IV collagen as the common autoantigen in antibasement membrane disease and Goodpasture syndrome. J Am Soc Nephrol 1995; 6:1178-1185.
27. Dehan P, WeberM, Zhang X, et al. Sera from patients with anti-GBM nephritis including Goodpasture syndrome show heterogeneous reactivity to recombinant NC1 domain of type IV collagen alpha chains. Nephrol Dial Transplant 1996; 11:2215-2222. (Pubitemid 26385917)
28. Rauf S, Kagawa M, Kishiro Y, et al. Nephritogenicity and alpha-chain composition of NC1 fractions of type IV collagen from bovine renal basement membrane. Virchows Arch 1996; 428:281-288. (Pubitemid 26265750)
29. Yang R, Hellmark T, Zhao J, et al. Antigen and epitope specificity of antiglomerular basement membrane antibodies in patients with Goodpasture disease with or without antineutrophil cytoplasmic antibodies. J Am Soc Nephrol 2007; 18:1338-1343. (Pubitemid 46536921)
30. Kashtan CE. Renal transplantation in patients with Alport syndrome. Pediatr Transplant 2006; 10:651-657. (Pubitemid 44186284)
31. Kalluri R, Torre A, Shield CF 3rd, et al. Identification of alpha3, alpha4, and alpha5 chains of type IV collagen as alloantigens for Alport posttransplant antiglomerular basement membrane antibodies. Transplantation 2000; 69:679-683. (Pubitemid 30129611)
32. Kang JS, Kashtan CE, Turner AN, et al. The alloantigenic sites of alpha3alpha4alpha5( IV) collagen: pathogenic X-linked Alport alloantibodies target two accessible conformational epitopes in the alpha5NC1 domain. J Biol Chem 2007; 282:10670-10677. (Pubitemid 47093427)
33. Borza DB. Autoepitopes and alloepitopes of type IV collagen: role in the molecular pathogenesis of anti-GBM antibody glomerulonephritis. Nephron Exp Nephrol 2007; 106:e37-e43.
34. Cui Z, Wang HY, Zhao MH. Natural autoantibodies against glomerular basement membrane exist in normal human sera. Kidney Int 2006; 69:894-899.
35. Cui Z, Zhao MH, Segelmark M, Hellmark T. Natural autoantibodies to myeloperoxidase, proteinase 3, and the glomerular basement membrane are present in normal individuals. Kidney Int 2010; 78:590-597.
36. Yang R, Cui Z, Hellmark T, et al. Natural anti-GBM antibodies from normal human sera recognize alpha3(IV)NC1 restrictively and recognize the same epitopes as anti-GBM antibodies from patients with anti-GBM disease. Clin Immunol 2007; 124:207-212. (Pubitemid 47064520)
37. Zhao J, Yan Y, Cui Z, et al. The immunoglobulinGsubclass distribution of anti- GBM autoantibodies against rHalpha3(IV)NC1 is associated with disease severity. Hum Immunol 2009; 70:425-429.
38. Cui Z, Zhao MH, Singh AK, Wang HY. Antiglomerular basement membrane disease with normal renal function. Kidney Int 2007; 72:1403-1408. (Pubitemid 350126772)
39. Kaneko Y, Nimmerjahn F, Madaio MP, Ravetch JV. Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors. J Exp Med 2006; 203:789-797.
40. Otten MA, Groeneveld TW, Flierman R, et al. Both complement and IgG Fc receptors are required for development of attenuated antiglomerular basement membrane nephritis in mice. J Immunol 2009; 183:3980-3988.
41. Than ME, Henrich S, Huber R, et al. The 1.9-A crystal structure of the noncollagenous (NC1) domain of human placenta collagen IV shows stabilization via a novel type of covalent Met-Lys cross-link. Proc Natl Acad Sci USA 2002; 99:6607-6612. (Pubitemid 34526180)
42. Vanacore RM, Ham AJ, Cartailler JP, et al. A role for collagen IV cross-links in conferring immune privilege to the Goodpasture autoantigen: structural basis for the crypticity of B cell epitopes. J Biol Chem 2008; 283:22737-22748.
43. Khoshnoodi J, Sigmundsson K, Cartailler JP, et al. Mechanism of chain selection in the assembly of collagen IV: a prominent role for the alpha2 chain. J Biol Chem 2006; 281:6058-6069. (Pubitemid 43847707)
44. Kang JS, Colon S, Hellmark T, et al. Identification of noncollagenous sites encoding specific interactions and quaternary assembly of alpha 3 alpha 4 alpha 5(IV) collagen: implications for Alport gene therapy. J Biol Chem 2008; 283:35070-35077.
45. Lebleu V, Sund M, Sugimoto H, et al. Identification of NC1 domain of {alpha}3 chain as critical for {alpha}3{alpha}4{alpha}5 type IV collagen network assembly. J Biol Chem 2010; 285:41874-41885.
46. Vanacore R, Ham AJ, Voehler M, et al. A sulfilimine bond identified in collagen IV. Science 2009; 325:1230-1234.
47. Borza DB, Bondar O, Colon S, et al. Goodpasture autoantibodies unmask cryptic epitopes by selectively dissociating autoantigen complexes lacking structural reinforcement: novel mechanisms for immune privilege and autoimmune pathogenesis. J Biol Chem 2005; 280:27147-27154. (Pubitemid 41040753)
48. Netzer KO, Leinonen A, Boutaud A, et al. The Goodpasture autoantigen. Mapping the major conformational epitope(s) of alpha3(IV) collagen to residues 17-31 and 127-141 of the NC1 domain. J Biol Chem 1999; 274:11267-11274.
49. Hellmark T, Burkhardt H, Wieslander J. Goodpasture disease. Characterization of a single conformational epitope as the target of pathogenic autoantibodies. J Biol Chem 1999; 274:25862-25868.
50. David M, Borza DB, Leinonen A, et al. Hydrophobic amino acid residues are critical for the immunodominant epitope of the Goodpasture autoantigen. A molecular basis for the cryptic nature of the epitope. J Biol Chem 2001; 276:6370-6377.
51. Luo W, Wang XP, Kashtan CE, Borza DB. Alport alloantibodies but not Goodpasture autoantibodies induce murine glomerulonephritis: protection by quinary crosslinks locking cryptic alpha3(IV) collagen autoepitopes in vivo. J Immunol 2010; 185:3520-3528.
52. Chen L, Hellmark T, Wieslander J, Bolton WK. Immunodominant epitopes of alpha3(IV)NC1 induce autoimmune glomerulonephritis in rats. Kidney Int 2003; 64:2108-2120. (Pubitemid 37449545)
53. Chen L, Hellmark T, Pedchenko V, et al. A nephritogenic peptide induces intermolecular epitope spreading on collagen IV in experimental autoimmune glomerulonephritis. J Am Soc Nephrol 2006; 17:3076-3081. (Pubitemid 44707768)
54. Meyers KE, Allen J, Gehret J, et al. Human antiglomerular basement membrane autoantibody disease in XenoMouse II. Kidney Int 2002; 61:1666-1673. (Pubitemid 34437920)
55. Kalluri R, Cantley LG, Kerjaschki D, Neilson EG. Reactive oxygen species expose cryptic epitopes associated with autoimmune Goodpasture syndrome. J Biol Chem 2000; 275:20027-20032. (Pubitemid 30441611)
56. Calvete JJ, Revert F, Blanco M, et al. Conformational diversity of the Goodpasture antigen, the noncollagenous-1 domain of the alpha3 chain of collagen IV. Proteomics 2006; 6 (Suppl 1):S237-S244.
57. Bolton WK, May WJ, Sturgill BC. Proliferative autoimmune glomerulonephritis in rats: a model for autoimmune glomerulonephritis in humans. Kidney Int 1993; 44:294-306. (Pubitemid 23228683)